Amanda Yufika

Amanda Yufika

Auto-generated profile, based on publicly available information

Amanda Yufika

Department of Family Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Physical Medicine and Rehabilitation Residency Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Harapan HarapanHarapan Harapan
Harapan Harapan
NINaoya Itoh
Naoya Itoh
AYAmanda Yufika
Amanda Yufika
WWwira winardi
wira winardi
SKSynat Keam
Synat Keam
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally. Perceived risk of acquiring disease has led many governments to institute a variety of control measures. We conducted a literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic. In this literature review, the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed.

17 February 2020 in Pathogens and Global Health
Verified
Journal Article
Closed access
Harapan HarapanHarapan Harapan
Harapan Harapan
Abdul Malik SetiawanAbdul Malik Setiawan
Abdul Malik Setiawan
AYAmanda Yufika
Amanda Yufika
SASamsul Anwar
Samsul Anwar
SWSri Wahyuni
Sri Wahyuni
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
After the first, imported, laboratory-confirmed case of monkeypox in human was reported in Singapore on May 2019, countries in Asia started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers. The aim of this study was to assess the knowledge of monkeypox among general practitioners (GPs) in Indonesia. A cross-sectional online survey was conducted. The survey collected participants’ knowledge on a 21-item scale and explanatory variables. A two-step logistic regression analysis was employed to assess the predictors of knowledge of monkeypox. A total of 432 GPs were included; 10.0% and 36.5% of them had a good knowledge using an 80% and 70% cutoff point for knowledge domain, respectively. No explanatory variables were associated with knowledge when using 80% cutoff point. Using the lower cutoff, there was lower knowledge among GPs who graduated from universities located in Sumatra or other islands versus Java (adjusted odds ratio (aOR): 0.53; 95%CI: 0.28–0.97, p = 0.041) and among those were older than 30 years compared to younger GPs (aOR: 0.61; 95%CI: 0.39–0.96, p = 0.033). GPs working in private clinics had less knowledge compared to GPs in community health centers (aOR: 0.55; 95%CI: 0.31–0.99, p = 0.047). In conclusion, knowledge of monkeypox among GPs in Indonesia is relatively low in all groups. Increasing knowledge of monkeypox will be key to improving the capacity of GPs to respond to human monkeypox cases and to report into a disease surveillance system.

1 March 2020 in Vaccine
Verified
Journal Article
Closed access
AYAmanda Yufika
Amanda Yufika
AWAbram Luther Wagner
Abram Luther Wagner
YNYusuf Nawawi
Yusuf Nawawi
NWNur Wahyuniati
Nur Wahyuniati
SASamsul Anwar
Samsul Anwar
Harapan HarapanHarapan Harapan
Harapan Harapan

1 December 2021 in Narra J
Verified
Journal Article
Open access
PDF file
Francesco rosielloFrancesco rosiello
Francesco rosiello
SASamsul Anwar
Samsul Anwar
AYAmanda Yufika
Amanda Yufika
RARashed Y. Adam
Rashed Y. Adam
MIMohajer Ih. Ismaeil
Mohajer Ih. Ismaeil
Malik SallamMalik Sallam
Malik Sallam
Vaccine hesitancy, defined as the reluctance or rejection in receiving a vaccine despite its availability, represents a major challenge to global health efforts aiming to control the ongoing COVID-19 pandemic. Understanding the possible factors correlated with COVID-19 vaccine hesitancy using a refined well-informed approach can be helpful to address the phenomenon. The current study aimed to evaluate COVID-19 vaccine acceptance rates using four hypothetical scenarios of varying levels of vaccine efficacy and safety profiles in ten Asian, African and South American countries. These scenarios included: 95% efficacy and 20% side effects (Vaccine A), 75% efficacy and 5% side effects (Vaccine B); 75% efficacy and 20% side effects (Vaccine C) and 50% efficacy and 5% side effects (Vaccine D). This study used a self-administered online survey that was distributed during February–May 2021. The total number of study respondents was 1337 with countries of residence as follows: India (21.1%), Pakistan (12.9%), Sudan (11.2%), Nigeria (9.3%), Iran (8.2%), Bangladesh and Brazil (7.9%), Chile (7.7%), Tunisia (7.6%), and Egypt (6.2%). The overall acceptance rates for COVID-19 vaccination were variable based on varying degrees of safety and efficacy as follows: 55.6% for Vaccine C, 58.3% for Vaccine D, 74.0% for Vaccine A and 80.1% for Vaccine B. The highest levels of COVID-19 vaccine acceptance were observed in Brazil followed by Chile across the four different safety and efficacy scenarios. The lowest COVID-19 vaccine acceptance rates were reported in Egypt and Tunisia for the low safety scenarios (20% side effects), and the low efficacy scenario (50% efficacy). The study revealed the potential effect of vaccine safety and efficacy on the intention to get COVID-19 vaccination. At the same efficacy level, higher possibility of side effects caused a large drop in COVID-19 vaccine acceptance rate. This indicates the importance of accurate communication regarding vaccine safety and efficacy on attitude towards the vaccine and intentions to get vaccinated. Regional differences in COVID-19 vaccine acceptance were observed with the Middle East/North African countries showing the lowest rates and the South American countries displaying the highest vaccine acceptance rates.

1 June 2020 in Acta Tropica
Verified
Journal Article
Closed access
Harapan HarapanHarapan Harapan
Harapan Harapan
Abdul Malik SetiawanAbdul Malik Setiawan
Abdul Malik Setiawan
AYAmanda Yufika
Amanda Yufika
SASamsul Anwar
Samsul Anwar
SWSri Wahyuni
Sri Wahyuni
MMMudatsir Mudatsir
Mudatsir Mudatsir

1 March 2019 in Vaccine
Verified
Journal Article
Closed access
Harapan HarapanHarapan Harapan
Harapan Harapan
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
AYAmanda Yufika
Amanda Yufika
YNYusuf Nawawi
Yusuf Nawawi
NWNur Wahyuniati
Nur Wahyuniati
AIAllison Imrie
Allison Imrie